Real science. Real results. A medically supervised weight loss program at our clinic in Doha, Qatar, built around your body, your metabolism and your life. Designed by doctors at WELLKINS Medical Centre, opposite the Westin Hotel, Ramada Signal, Doha.
The WELLKINS Weight Management Program is a medically supervised slimming and wellness program for adults in Doha. It starts with a blood panel and clinical assessment, then builds a personalized plan around your metabolism, lifestyle and health conditions, not a generic diet.
Clinically assessed from day one
Blood panel, physical examination and metabolic profiling before any plan is created. We treat the cause, not just the symptom.
Specialist doctors on the team
Internal Medicine consultants and DHP-licensed GPs in Doha, all managing your plan together, not in silos.
Continuous monitoring and follow-up
Regular check-ins with your doctor throughout the 4, 6 or 12-month program. Your plan adjusts as your body changes.
GLP-1 medications available
Where clinically appropriate, our Internal Medicine team can evaluate and prescribe GLP-1 receptor agonists including the Ozempic class, safely supervised throughout.
Every patient is seen by a qualified doctor, not a coach or nutritionist. Your plan is medically grounded from day one.

MBBS, MD (Internal Medicine)
DHP License: P14173 · OEUK Certified Physician

MBBS
DHP License: P14653
MBBS
DHP License: P17852
Both pathways are medically supervised by our doctors at WELLKINS and begin with a clinical assessment. Your doctor recommends the right approach based on your blood panel and health profile.
Medication is prescribed only after your clinical assessment confirms suitability. Costs below are per pen, self-pay. Not included in the QR 500 package.
| Medication | How it works | Cost per pen |
|---|---|---|
|
Ozempic
Semaglutide · Once weekly
|
Targets GLP-1 receptors. Extensively studied for glycemic control and weight management. Proven cardiovascular risk reduction. | QR 474 |
|
Wegovy
Semaglutide · Once weekly
|
Higher maintenance dose specifically approved for chronic weight management. Clinically indicated for BMI-based weight loss. | From QR 796 |
|
Mounjaro
Tirzepatide · Once weekly
|
Dual GIP and GLP-1 receptor agonist. Clinical trials show superior total weight loss compared to single-receptor agonists. | QR 1,474 |
Close clinical supervision ensures safe dose titration, monitors nutritional adequacy and catches any adverse reactions early.
GLP-1 medications slow gastric emptying and signal fullness to the brain. Most side effects are temporary and manageable. Your doctor monitors you throughout and adjusts your plan as needed.
If lifestyle modification alone isn't enough, our Internal Medicine specialists can evaluate whether GLP-1 receptor agonists including medications in the Ozempic and Mounjaro class, are clinically appropriate for you. Medically supervised, safely prescribed and integrated into your personalized plan.
Ready to start? Book your consultation today.
Choose your doctor and book the QR 250 pre assessment package or the QR 500 GLP-1 pre-initiation assessment.
Real feedback from patients who started their journey with WELLKINS.
"The blood tests found a thyroid issue I didn't know about. Once that was addressed, the weight actually moved."
Sara M. · 12-Month Program · Lost 18 kg"The plan wasn't just about eating less. It was about eating right for my body specifically. Completely different approach."
Rajan K. · 6-Month Program · Lost 11 kg"I was managing diabetes alongside the program. No conflicting advice, no confusion. It felt genuinely professional."
Amira H. · 6-Month Program · Doha* Representative patient experiences. Individual results vary. Names anonymised for privacy.
Got questions? We've got answers. If you can't find what you need, just book a consultation and our team will help.
Begin with a QR 500 GLP-1 pre-initiation assessment and let our doctors build your plan from there.
Book a Consultation